Posted on

Can Nutraceutical Support of Visual Function Help Protect the Brain from Concussion?

Athlete hurt on the field.
By Dr. Dorothy Hitchmoth

In the recent movie Concussion, actor Will Smith, playing the now infamous doctor Bennet Omalu, says, “repetitive head trauma chokes the brain”.   I know this is true.  My 20 years as a VA eye doctor is a privilege that bears the reality of the effects of repeat brain trauma as well as the perseverance embedded in the souls of our nation’s finest men and women.  My perspective on treating these patients is hardly mired given my proverbial view to the brain.

Science has proven that the eye and brain are inseparable and can really be thought of as a common system bound by shared anatomy, function and blood supply.  In fact, it is a well-conceived notion that the eye is the canary of the mind.  “The retina is actually a piece of the brain that has grown into the eye and processes neural signals when it detects light” at about “the same rate as an Ethernet connection”, according to NIH researchers. 1

The retina is responsible for capturing visual information and transmitting it to the brain in a variety of ways. The nerve responsible for vision (optic nerve) is easily seen and measured during an eye exam. This nerve traverses the entire brain and research has already revealed several biomarkers of brain disease that can be visualized through the eye.

Can nutraceutical support of visual function help protect the brain from concussion?
Measuring the optic nerve and exam of the lens in the eye has revealed clues about Alzheimer’s disease, multiple sclerosis, neuromyelitis optica, glaucoma and Parkinson’s disease. 2-11 Similarly, the eye reveals clues about patients affected by chronic brain injury such as concussion and multiple concussion (mTBI). Optic nerve integrity can be measured by ocular coherence tomography (OCT), visual evoked potential (VEP), pattern electroretinagram, and pupillography. These tests are performed by eye doctors and help detect damage in the eye and brain. 12-14 Moreover, light absorbing pigments in the retina, also known as macular pigments, can be measured through a technique called macular pigment optical density (MPOD). This test is a simple, two-minute test that many eye doctors perform in office that provides insight about nutrient intake of lutein and zeaxanthin.   Lutein and zeaxanthin are plant pigments seen in some of the healthiest fruits and vegetables that protect the visual center of the retina known as the macula. Low measures of MPOD have been associated with disease states such as macular degeneration, diabetes, glaucoma, poor visual performance and lower cognitive function.  Normal and optimized MPOD measures are associated with significantly improved visual function in study groups of high performance athletes and the elderly, two groups at risk for brain injury.  Study groups who  took supplemental lutein and zeaxanthin had significantly improved measures of acuity, contrast acuity, glare disability, and other measures of visual function.  These measures are very important in both high performance athletics as well as improved driving vision in the elderly for example.15-26

Given these insights, it should not be surprising that nutrients that support eye health are also implicated in brain homeostasis.

Omega 3 polyunsaturated fatty acid (PUFA) (fish oil: DHA/EPA), alpha lipoic acid, Vitamins A, D, E, B6, B12, Selenium, Manganese, CoQ10, anthocyanin, zeaxanthin, and lutein are all nutrients that support healthy eye and brain function.   This list is not exhaustive and other dietary and supplemental source nutrients to include certain antioxidants such as polyphenols and curcumin as well as other medium chain fatty acids, such as those found in coconut oil, are being studied for potential benefit in neurodegenerative conditions to include brain injury. 26-34 It is also important to know that the eye and brain has the highest concentration of lutein, zeaxanthin and DHA/EPA (omega 3 -fats) in the body.34-37

The nutrients noted here are important for eye-brain protection and function despite the fact that many factors and complex mechanisms have been identified in diseases and/or trauma to these important organs-many of which have yet to be fully understood. There is a need for more research in this area, however, there is general scientific consensus that inflammation, oxidative stress and interruption of the eye-brain-blood barrier are implicated in the chronic stages of eye and brain disease such glaucoma, macular degeneration, diabetic retinopathy as well as early and late phase effects of concussion.38-40  The nutrients implicated herein are regularly prescribed by eye doctors because many of these nutrients are needed for improved visual performance and in the management of age-related macular degeneration and dry eye disease.  Similarly, certain lifestyle implications such as dietary glycemic load (sugar), body weight (obesity), smoking and other epigenetic factors have all been associated with poorer outcomes in patients with certain eye disease and those who experience brain trauma.

Therefore, it seems it is not a scientific leap to beg the question:  Can nutraceutical support of visual function help protect the brain from concussion?  Future research will better answer this question, however, it seems prudent to advise patients who are at risk for concussion about the importance of good nutrition and smoking cessation.  This is especially important advice for young athletes, who have developing brains and who are high risk for concussion.  Preparing the visual system and brain with a healthy diet or dietary sourced nutrients will prevent other poor outcomes associated with a “junk food and beer” lifestyle. Seems we have nothing to lose. Similarly, measuring MPOD in the eye doctor’s office may provide insight about the dietary habits and visual abilities of these young athletes.  Athletes with low MPOD can be advised to change their diets and consider supplemental forms of important vision nutrients.   I see little risk in preparing athletes for a lifetime of good health habits with the presumption that your good advice may help thwart some of the effect of brain injury as well as help in recovery.   The concept of “pre-treatment” is an important emerging science that bears attention.  Concussion rates in the NFL were reported to have increased 58% last year and as many as one in five high school athletes will suffer a concussion. 41-42 These facts warrant better prevention programs like those at University of Cincinnati.  Dr. Joe Clark, professor of neurology and associate director of the UC Sports Neuroscience Initiative (SNI), is part of a holistic concussion prevention program at UC that has helped athletes strengthen their peripheral vision, reaction time and eye-hand coordination.  His training program has resulted in a significant drop in season play concussion.

In my view, eye doctors (optometrists and ophthalmologists) are also well-positioned to impact concussion outcomes especially in brain injury associated with mild and repeat concussion because these are often underdiagnosed.  Optometrists should be part of the care team in this fight because they interface with two-thirds of the population.  More importantly, they are experts in the measurement of eye-brain dysfunction, they provide neuro-ocular rehabilitation to patients with brain injury, and they are seasoned purveyors of risk who regularly give health and medical advice to patients.  Perhaps one day a visit to the eye doctor will be a routine and required part of pre-concussion prevention programs.

Technological advancements in the measurement of eye and brain function, head and neck protection, and brain science, will carve a future path that helps us protect our brains even better, however, I believe we can impact patient lives now.  A little food-for thought.

Download Your Free EBook Zeaxanthin's Role in Optomizing Vision, Athletic Peformance


Dr. Hitchmoth is Chief of Optometry and Director of Residency at the VAMC White River Junction. She is a private practice owner and CEO of New England Telehealth.  Dr. Hitchmoth is a nationally-recognized award-winning professor, lecturer, educator and thought leader. Her publication and research interest centers on retinal biomarkers of systemic disease.  @eyedocdorothy

Disclosures: Dr. Hitchmoth is a paid consultant for Zeavision, LLC and Shire Ophthalmics Inc


  1. Koch, Kristin et al., How Much the Eye Tells the Brain. Current Biology , Volume 16 , Issue 14 , 1428 – 1434.
  1. Chan HL; Brain connectivity of patients with Alzheimer’s disease by coherence and cross mutual information of electroencephalograms during photic stimulation. Med Eng Phys. 2013; 35(2):241-52 (ISSN: 1873-4030)
  1. Jones-Odeh E; Hammond CJ, How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis? Eye (Lond). 2015; 29(10):1270-84.
  1. Simao LM, The contribution of optical coherence tomography in neurodegenerative diseases. Curr Opin Ophthalmol. 2013; 24(6):521-7.
  1. Kirbas S; Turkyilmaz K; Anlar O; Tufekci A; Durmus M, Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol. 2013; 33(1):58-61.
  1. Parisi V, Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease. Semin Ophthalmol. 2003; 18(2):50-7.
  1. Parisi V; Restuccia R; Fattapposta F; Mina C; Bucci MG; Pierelli F, Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol. 2001; 112(10):1860-7. Disease Markers
  1. Tian Tian, Boai Zhang, Yanjie Jia, and Zhaoming Li, “Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer’s Disease,” Disease Markers, vol. 2014, Article ID 826503, 5 pages, 2014. doi:10.1155/2014/826503
  1. Kanamori A, Nakamura M, Yamada Y, Negi A. Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Ganglion Cell Complex in Traumatic Optic Neuropathy. Arch Ophthalmol. 2012;130(8):1067-1069.
  1. CUNHA, Leonardo Provetti; COSTA-CUNHA, Luciana Virginia Ferreira; MALTA, Roberto Freire Santiago and  MONTEIRO, Mário Luiz Ribeiro. Comparison between retinal nerve fiber layer and macular thickness measured with OCT detecting progressive axonal loss following traumatic optic neuropathy. Arq. Bras. Oftalmol. [online]. 2009, vol.72, n.5 [cited  2016-01-25], pp. 622-625
  1. R M Vessani, L P Cunha, M L R Monteiro,Progressive macular thinning after indirect traumatic optic neuropathy documented by optical coherence tomography. Br J Ophthalmol 2007;91:697-698
  1. Yadav NK; Ciuffreda KJ, Objective assessment of visual attention in mild traumatic brain injury (mTBI) using visual-evoked potentials (VEP). Brain Inj. 2015; 29(3):352-65.
  1. Freed S; Hellerstein LF, Visual electrodiagnostic findings in mild traumatic brain injury. Brain Inj. 1997; 11(1):25-36.
  1. Sarno S; Erasmus LP; Lippert G; Frey M; Lipp B; Schlaegel W, Electrophysiological correlates of visual impairments after traumatic brain injury. Vision Res. 2000; 40(21):3029-38.
  1. Feeney, Joanne et al. , Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults, Neurobiology of Aging , Volume 34 , Issue 11 , 2449 – 2456.
  1. Renzi, Lisa M. et al. Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiology of Aging , Volume 35 , Issue 7 , 1695 – 1699
  1. Hammond BR; Fletcher LM, Influence of the dietary carotenoids lutein and zeaxanthin on visual performance: application to baseball. Am J Clin Nutr. 2012; 96(5):1207S-13S.
  1. Renzi LM; Bovier ER; Hammond BR, A role for the macular carotenoids in visual motor response. Nutr Neurosci. 2013; 16(6):262-8
  1. Bovier ER; Hammond BR, A randomized placebo-controlled study on the effects of lutein and zeaxanthin on visual processing speed in young healthy subjects. Arch Biochem Biophys. 2015; 572:54-7.
  1. Igras E; Loughman J; Ratzlaff M; O’Caoimh R; O’Brien C, Evidence of lower macular pigment optical density in chronic open angle glaucoma. Br J Ophthalmol. 2013; 97(8):994-8.
  1. Siah WF; Loughman J; O’Brien C, Lower Macular Pigment Optical Density in Foveal-Involved Glaucoma.Ophthalmology. 2015; 122(10):2029-37.
  1. Waldstein SM; Hickey D; Mahmud I; Kiire CA; Charbel Issa P; Chong NV, Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema. Eye (Lond). 2012; 26(8):1078-85.
  1. Loane E; Nolan JM; McKay GJ; Beatty S, The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. Exp Eye Res. 2011; 93(5):592-8.
  1. Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM, Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial. Br J Ophthalmol. 2015; 99(3):371-5
  1. Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L, Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015; 56(1):252-8.
  1. Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry.  2011; 82(11):667-680.e6
  1. Fernando Gómez-Pinilla, Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008 Jul; 9(7): 568–578.
  1. Web: The Linus Pauling Institute, Micronutrient Information Center.
  1. Caldwell SB; Smith D; Wilson FC, Impact of paroxysmal sympathetic hyperactivity on nutrition management after brain injury: a case series. Brain Inj. 2014; 28(3):370-3
  1. Barberger-Gateau P, Nutrition and brain aging: how can we move ahead? Eur J Clin Nutr. 2014; 68(11):1245-9 (ISSN: 1476-5640)
  2. Web Reference: Diet and Nutrition, American Academy of Ophthalmology:
  3. Schweigert FJ; Reimann J, Micronutrients and their relevance for the eye–function of lutein, zeaxanthin and omega-3 fatty acids. Klin Monbl Augenheilkd.  2011; 228(6):537-43.
  4. Liu Y, et al., Visible Light-Induced Lipid Peroxidation of Unsaturated Fatty Acids in the Retina and the Inhibitory Effects of Blueberry Polyphenols. J Agric Food Chem. 2015; 63(42):9295-305.
  5. Fernando WM; Martins IJ; Goozee KG; Brennan CS; Jayasena V; Martins RN, The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: potential mechanisms of action. Br J Nutr.  2015; 114(1):1-14.
  6. Chang CY1, Ke DS, Chen JY. Essential fatty acids and human brain. Acta Neurol Taiwan. 2009 Dec;18(4):231-41.
  7. Joanne Bradbury, Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human Brain. Nutrients 2011 May; 3(5): 529–554.
  8. The Handbook of Nutrition, Diet and the Eye, Kings College London, UK, Copyright; Elsivier, 2014
  9. Kruk J; Kubasik-Kladna K; Aboul-Enein HY,The Role Oxidative Stress in the Pathogenesis of Eye Diseases: Current Status and a Dual Role of Physical Activity. Mini Rev Med Chem. 2015; 16(3):241-57.
  10. de Oliveira DM; Ferreira Lima RM; El-Bachá RS, Brain rust: recent discoveries on the role of oxidative stress in neurodegenerative diseases. Nutr Neurosci. 2012; 15(3):94-102.
  11. Helmy A1, De Simoni MG, Guilfoyle MR, Carpenter KL, Hutchinson PJ., Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol. 2011 Nov;95(3):352-72.
  12. Web Reference:
  1. Web Reference:
  1. Web Reference: